RPE Cell Expansion on Suspendable Microcarriers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for large-scale production of retinal pigment epithelial (RPE) cells are labor-intensive, resource-consuming, and prone to contamination and variability, limiting their availability for treating conditions like age-related macular degeneration and retinitis pigmentosa.
Innovation Solution
The use of pluripotent stem cells differentiated into RPE cells and expanded on suspendable cell support matrices, such as microcarriers, in a controlled dynamic suspension system, allowing for scalable and controlled production of RPE cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional two-dimensional culture methods are used for RPE cell production, then cells can be grown on standard surfaces, but the process becomes labor intensive, requires large footprints, consumes excess resources, and harbors high risk for contamination and variability
Solution Approach 1:
The patent transitions from traditional two-dimensional static culture surfaces to three-dimensional dynamic suspension culture using microcarriers. RPE cells are cultured on microcarrier beads suspended in bioreactors, enabling cells to grow on the surface of moving particles rather than fixed flat surfaces. This dimensional transition dramatically increases production capacity while reducing footprint and improving controllability.
Solution Approach 2:
The patent replaces manual, labor-intensive two-dimensional culture operations with automated bioreactor systems that use mechanical agitation to suspend and mix microcarriers. The dynamic suspension system uses controlled mechanical movement rather than manual handling, enabling scalable production with reduced labor and improved consistency.
2Reliability
If traditional two-dimensional culture methods are used, then standard culture equipment can be employed, but contamination risk and lot variability increase due to uncontrolled open systems
Solution Approach 1:
The patent employs closed bioreactor systems that create controlled, sterile environments for microcarrier suspension culture. These closed systems prevent contamination from the external environment while maintaining optimal growth conditions, replacing the open two-dimensional culture systems that are susceptible to contamination.
Solution Approach 2:
The patent replaces manual culture operations with automated bioreactor systems that provide precise control over culture parameters. This mechanical automation eliminates human intervention that could introduce contamination or variability, ensuring consistent, reproducible results across different cell lots.
3Quantity of substance
If adult or fetal RPE tissues are used as donor sources, then authentic RPE cells can be obtained, but sufficient tissue supply is limited and ethical concerns arise
Solution Approach 1:
The patent uses pluripotent stem cells that can be differentiated into RPE cells under controlled conditions. By changing the differentiation parameters and culture conditions, large quantities of authentic RPE cells can be produced from a single stem cell source, eliminating the need for multiple fetal or adult donor tissues.
Solution Approach 2:
The patent establishes stem cell banks with pre-differentiated RPE cells that can be stored and used on demand. This preliminary preparation of cell sources eliminates the need for ethical concerns associated with fetal tissue donation and ensures sufficient supply without requiring additional donor tissues at the time of treatment.
Data Source
AI summary
Presented herein are methods and compositions for expanding RPE cells with the use of a suspendable cell support matrix. Also provided are pharmaceutical compositions containing RPE cells, and methods of treating an eye disorder or disease using RPE cells.